IND Diagnostic Inc.
⚠️ Moderate Risk
FEI: 3003148151 • Delta, British Columbia • CANADA
FEI Number
3003148151
Location
Delta, British Columbia
Country
CANADAAddress
1629 Foster's Way, , Delta, British Columbia, Canada
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
LACKS FIRM
The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
LACKS N/C
The article is in package form and appears to not have a label containing an accurate statement of the quantity of the contents in terms of weight, measure or numerical count and no variations or exemptions have been prescribed by regs.
INCONSPICU
Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
LBLG ADVER
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded because its labeling is misleading in a particular, namely that it fails to reveal facts (non-sterility) that are material with respect to consequences which may result from the use of the article according to the labeling, or advertising, or under such conditions of use as are customary or usual.
NEW VET DR
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 5/30/2012 | 75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN | 341REGISTERED | New Orleans District Office (NOL-DO) |
| 10/13/2010 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | 508NO 510(K) | Seattle District Office (SEA-DO) |
| 8/4/2010 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | Minneapolis District Office (MIN-DO) | |
| 11/12/2008 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | Seattle District Office (SEA-DO) | |
| 6/12/2008 | 88LDTREAGENT, GENERAL PURPOSE | Cincinnati District Office (CIN-DO) | |
| 12/26/2007 | 81NPRTEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR | 118NOT LISTED | Florida District Office (FLA-DO) |
| 5/14/2007 | 83JXAKIT, SCREENING, URINE | 336INCONSPICU | New York District Office (NYK-DO) |
| 7/26/2006 | 83JTODISCS, STRIPS AND REAGENTS, MICROORGANISM DIFFERENTIATION | New Orleans District Office (NOL-DO) | |
| 7/26/2006 | 75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN | New Orleans District Office (NOL-DO) | |
| 7/26/2006 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | New Orleans District Office (NOL-DO) | |
| 7/10/2006 | 67A45PENICILLIN CATEGORY I, TYPE A MEDICATED ARTICLE | New Orleans District Office (NOL-DO) | |
| 5/9/2006 | 83LOMTEST, HEPATITIS B (B ANTIGEN, B SURFACE ANTIGEN, BE ANTIGEN) | Cincinnati District Office (CIN-DO) | |
| 11/22/2005 | 75CEPRADIOIMMUNOASSAY, LUTEINIZING HORMONE | New Orleans District Office (NOL-DO) | |
| 11/3/2005 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | Seattle District Office (SEA-DO) | |
| 9/18/2005 | 75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN | 341REGISTERED | New Orleans District Office (NOL-DO) |
| 9/15/2005 | 75JHIRADIOIMMUNOASSAY, HUMAN CHORIONIC GONADOTROPIN | New Orleans District Office (NOL-DO) | |
| 9/15/2005 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | New Orleans District Office (NOL-DO) | |
| 9/6/2005 | 75CEPRADIOIMMUNOASSAY, LUTEINIZING HORMONE | 16DIRECTIONS | Cincinnati District Office (CIN-DO) |
| 9/6/2005 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | 16DIRECTIONS | Cincinnati District Office (CIN-DO) |
| 4/8/2005 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | 118NOT LISTED | Cincinnati District Office (CIN-DO) |
| 5/6/2004 | 81MTNTEST, SYPHILIS, TREPONEMAL | Seattle District Office (SEA-DO) | |
| 1/28/2004 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | Seattle District Office (SEA-DO) | |
| 12/3/2003 | 83JTODISCS, STRIPS AND REAGENTS, MICROORGANISM DIFFERENTIATION | New Orleans District Office (NOL-DO) | |
| 11/19/2003 | 57YY99BIOLOGICAL IN-VIVO AND IN-VITRO DIAGNOSTICS, N.E.C. | 118NOT LISTED | New Orleans District Office (NOL-DO) |
| 10/23/2003 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | 508NO 510(K) | New Orleans District Office (NOL-DO) |
| 8/11/2003 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | 341REGISTERED | Baltimore District Office (BLT-DO) |
| 7/7/2003 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | New York District Office (NYK-DO) | |
| 5/22/2003 | 75JHJAGGLUTINATION METHOD, HUMAN CHORIONIC GONADOTROPIN | Florida District Office (FLA-DO) | |
| 5/21/2003 | 75JJXSINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED) | Cincinnati District Office (CIN-DO) | |
| 2/6/2003 | 75JKATUBES, VIALS, SYSTEMS, SERUM SEPARATORS, BLOOD COLLECTION | 237NO PMA | Florida District Office (FLA-DO) |
| 12/12/2002 | 88LIYCURVICAL MUCUS PENETRATION TEST | Cincinnati District Office (CIN-DO) | |
| 12/12/2002 | 75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER | Cincinnati District Office (CIN-DO) | |
| 8/13/2002 | 88LDTREAGENT, GENERAL PURPOSE | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is IND Diagnostic Inc.'s FDA import refusal history?
IND Diagnostic Inc. (FEI: 3003148151) has 33 FDA import refusal record(s) in our database, spanning from 8/13/2002 to 5/30/2012.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. IND Diagnostic Inc.'s FEI number is 3003148151.
What types of violations has IND Diagnostic Inc. received?
IND Diagnostic Inc. has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about IND Diagnostic Inc. come from?
All FDA import refusal data for IND Diagnostic Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.